The value of pharmacogenetic markers for personalized approach to the statins treatment
This review presents the most studied genetic markers which are risk factors for adverse drug reactions in patients who are treated with statins and/or associated with resistance to them. We have considered the possible practical advice for individual therapy with statins in patients with a known ge...
Guardado en:
Autores principales: | N. V. Kokh, G. I. Lifshits |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85a66bbe548a43ada191f55e6a9bef91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen R, et al.
Publicado: (2016) -
A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care
por: Charles A. Brunette, et al.
Publicado: (2021) -
Mutations in <italic toggle="yes">hmg1</italic>, Challenging the Paradigm of Clinical Triazole Resistance in <named-content content-type="genus-species">Aspergillus fumigatus</named-content>
por: Jeffrey M. Rybak, et al.
Publicado: (2019) -
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma S, et al.
Publicado: (2019) -
Muscle Response to the Association of Statin and Physical Exercise in Rats
por: Bonfim,Mariana Rotta, et al.
Publicado: (2009)